ARSA and metachromatic leukodystrophy: Metachromatic leukodystrophy is a fatal neurodegenerative lysosomal storage disease caused by genetic defects of the ARSA enzyme that currently lacks definitive treatment and might benefit from the development of novel gene/NSC‐based therapeutics.